Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomatitis 1 Pancreatic Neoplasms 1 Glioblastoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Radiosurgery 12 Temozolomide 10 Radiotherapy 10 Magnetic Resonance Spectroscopy 7 Erlotinib Hydrochloride 6 Bevacizumab 6 Surgical Procedures, Operative 5 Pemetrexed 5 Gefitinib 5 Drug Therapy 5 Carboplatin 5 pyrotinib 4 icotinib 4 aumolertinib 4 Trastuzumab 3 Spermine Synthase 3 Radiation 3 Lomustine 3 Etoposide 3 Dexmedetomidine 3 Chlorotoxin 3 Carmustine 3 osimertinib 2 camrelizumab 2 apatinib 2 Tyrosine Kinase Inhibitors 2 Thiotepa 2 Surveys and Questionnaires 2 Sevoflurane 2 Propofol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Brain Neoplasms × Losartan × Clear all

NCT03951142 2023-11-01

ImPRESS

Oslo University Hospital

Phase 2 Unknown

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡